BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14572550)

  • 1. [Application of molecular biology techniques to malignant haematology].
    Delabesse E; Asnafi V; Macintyre E
    Transfus Clin Biol; 2003 Oct; 10(5):335-52. PubMed ID: 14572550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The immunology laboratory in malignant blood diseases].
    López Berges MC; Vidriales B; Ocqueteau M; Orfao A
    Sangre (Barc); 1996 Aug; 41(4):281-8. PubMed ID: 8984669
    [No Abstract]   [Full Text] [Related]  

  • 3. Modern molecular diagnostics and the management of haematological malignancies.
    Morgan GJ; Pratt G
    Clin Lab Haematol; 1998 Jun; 20(3):135-41. PubMed ID: 9681227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview. Cytogenetic analysis in haematology.
    Bain BJ
    Best Pract Res Clin Haematol; 2001 Sep; 14(3):463-77. PubMed ID: 11640865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diagnosis of hematopoietic and lymphoid neoplasms.
    Jevremovic D; Viswanatha DS
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):903-33. PubMed ID: 19577174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In situ hybridization techniques. Basis and applications in hematologic neoplasias].
    Espinet B; Lloveras E; Solé F
    Sangre (Barc); 1999 Aug; 44(4):261-7. PubMed ID: 10589277
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytogenetics in the study of malignant blood diseases].
    García JL; Hernández JM; Gutiérrez NC; Fernández P; Ríos A
    Sangre (Barc); 1996 Aug; 41(4):289-95. PubMed ID: 8984670
    [No Abstract]   [Full Text] [Related]  

  • 8. [Molecular anomalies in malignant hemopathies].
    Mauvieux L; Macintyre E
    Presse Med; 1997 Jun; 26(21):1005-7. PubMed ID: 9239151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular biology in malignant blood diseases. Clinical applications. Study of immunoglobulin and T-cell receptor genes and molecular analysis of the translocations].
    González M; García-Sanz R; Vargas M; Balanzategui A; Chillón MC; Mateos MV; San Miguel JF
    Sangre (Barc); 1996 Aug; 41(4):321-34. PubMed ID: 8984674
    [No Abstract]   [Full Text] [Related]  

  • 10. Advances in the management of malignant hemopathies: the role of statins.
    Mihăilă RG
    Recent Pat DNA Gene Seq; 2013 Apr; 7(1):57-61. PubMed ID: 22670602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New molecular methods for classification, diagnosis and therapy prediction of hematological malignancies.
    Zvara A; Hackler L; Nagy ZB; Micsik T; Puskás LG
    Pathol Oncol Res; 2002; 8(4):231-40. PubMed ID: 12579208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA fingerprinting in leukemia.
    Pakkala S
    Int J Clin Lab Res; 1992; 21(4):269-72. PubMed ID: 1591378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of new technologies in the detection of balanced translocations in hematologic disorders.
    Shaffer LG; Schultz RA; Ballif BC
    Curr Opin Genet Dev; 2012 Jun; 22(3):264-71. PubMed ID: 22336526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FISH panels for hematologic malignancies.
    Sreekantaiah C
    Cytogenet Genome Res; 2007; 118(2-4):284-96. PubMed ID: 18000382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA diagnosis in hematological malignancies].
    Nara N
    Rinsho Byori; 2001 Mar; Suppl 115():37-44. PubMed ID: 11391935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune-checkpoint and hemopathies].
    Burroni B; Broudin C; Damotte D; Laurent C
    Ann Pathol; 2017 Feb; 37(1):101-110. PubMed ID: 28161001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for hematologic cancers.
    Misra RR; Pinsky PF; Srivastava S
    Hematol Oncol Clin North Am; 2000 Aug; 14(4):907-24, ix-x. PubMed ID: 10949780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular diagnosis and new gene engineering in hematological malignancies].
    Funato T; Fujiwara J; Fujimaki S; Kaku M
    Rinsho Byori; 2000 Oct; 48(10):887-91. PubMed ID: 11215098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA Dysregulation in Childhood Hematological Cancer.
    Carvalho de Oliveira J; Molinari Roberto G; Baroni M; Bezerra Salomão K; Alejandra Pezuk J; Sol Brassesco M
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular diagnosis in hematopathology].
    Ott G
    Pathologe; 2002 May; 23(3):174-6. PubMed ID: 12089784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.